This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1990:13:57-86.

Polysaccharides and membrane vaccines

Affiliations

PMID: 1970737

Review

Polysaccharides and membrane vaccines

J T Poolman. Adv Biotechnol Processes. 1990.

. 1990:13:57-86.

Author

Affiliation

¹ Department of Bacterial Vaccine Development, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.

PMID: 1970737

No abstract available

PubMed Disclaimer

Similar articles

Second generation meningococcal OMP-LPS vaccines.
Poolman JT, van der Ley PA, Wiertz EJ, Hoogerhout P. Poolman JT, et al. NIPH Ann. 1991 Dec;14(2):233-41. NIPH Ann. 1991. PMID: 1725922 No abstract available.
Development of a meningococcal vaccine.
Poolman JT. Poolman JT. Infect Agents Dis. 1995 Mar;4(1):13-28. Infect Agents Dis. 1995. PMID: 7728353 Review. No abstract available.
Vaccines against meningococcal meningitis: current status.
[No authors listed] [No authors listed] Epidemiol Bull. 1994 Jul;15(2):13-5. Epidemiol Bull. 1994. PMID: 8086300 Review. No abstract available.
Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial.
Wedege E, Bjune G, Frøholm LO, Høiby EA, Rosenqvist E. Wedege E, et al. NIPH Ann. 1991 Dec;14(2):183-4; discussion 185-6. NIPH Ann. 1991. PMID: 1812431 Clinical Trial. No abstract available.
Production and control of Neisseria meningitidis vaccines.
Frasch CE. Frasch CE. Adv Biotechnol Processes. 1990;13:123-45. Adv Biotechnol Processes. 1990. PMID: 2110462 Review. No abstract available.

See all similar articles

Cited by

Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis.
Lee JW, O'Brien CN, Guidry AJ, Paape MJ, Shafer-Weaver KA, Zhao X. Lee JW, et al. Can J Vet Res. 2005 Jan;69(1):11-8. Can J Vet Res. 2005. PMID: 15745217 Free PMC article.
Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.
Verheul AF, Van Gaans JA, Wiertz EJ, Snippe H, Verhoef J, Poolman JT. Verheul AF, et al. Infect Immun. 1993 Jan;61(1):187-96. doi: 10.1128/iai.61.1.187-196.1993. Infect Immun. 1993. PMID: 8418041 Free PMC article.
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
Verheul AF, Snippe H, Poolman JT. Verheul AF, et al. Microbiol Rev. 1993 Mar;57(1):34-49. doi: 10.1128/mr.57.1.34-49.1993. Microbiol Rev. 1993. PMID: 8464406 Free PMC article. Review.
Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis.
Scholten RJ, Bijlmer HA, Valkenburg HA, Dankert J. Scholten RJ, et al. Epidemiol Infect. 1994 Feb;112(1):115-24. doi: 10.1017/s0950268800057472. Epidemiol Infect. 1994. PMID: 8119350 Free PMC article.
Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine.
Pérez O, Lastre M, Lapinet J, Bracho G, Díaz M, Zayas C, Taboada C, Sierra G. Pérez O, et al. Infect Immun. 2001 Jul;69(7):4502-8. doi: 10.1128/IAI.69.7.4502-4508.2001. Infect Immun. 2001. PMID: 11401992 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database